RBA Form 4: Adam DeWitt Records Dividend Equivalent Rights on RSUs
Rhea-AI Filing Summary
Adam DeWitt, a director of RB Global Inc. (RBA), received dividend equivalent rights on 09/18/2025 related to deferred share units and a 2025 RSU grant. The Form 4 reports the accrual and immediate acquisition of 23 dividend equivalent rights tied to deferred share units and 5 dividend equivalent rights tied to 2025 restricted share units; each right represents a contingent economic equivalent to one RBA common share and carries a $0 price. The filing shows the beneficial ownership following these transactions as 503 common shares (for the deferred share unit-related rights) and 10 common shares (for the 2025 RSU-related rights). The Form 4 was signed by an attorney-in-fact on 09/19/2025.
Positive
- Director alignment strengthened: Reporting person received dividend equivalent rights linked to deferred share units and RSUs, aligning interests with shareholders.
- Transparent, timely disclosure: Form 4 filed and signed (09/19/2025) showing transaction date 09/18/2025 and post-transaction beneficial ownership.
Negative
- None.
Insights
TL;DR: Director received small non-cash equity-related credits; immaterial to valuation but increases insider alignment.
The reported transactions are non-cash dividend equivalent rights tied to deferred share units and RSUs, totaling 28 contingent rights acquired on 09/18/2025 and reflected at a $0 price. These instruments entitle the holder to the economic equivalent of common shares upon vesting/exercise and modestly increase the reporting person's share-equivalent stake as shown by the post-transaction beneficial ownership figures. From a financial-materiality standpoint, the amounts are small and unlikely to affect company valuation or liquidity, but they do slightly increase insider exposure to share performance.
TL;DR: Routine insider award disclosure; consistent with executive compensation practices and Rule 16 reporting.
The Form 4 discloses routine accrual and acquisition of dividend equivalent rights connected to deferred share units and a 2025 RSU grant for a director. The form is properly executed by an attorney-in-fact and timely filed following the 09/18/2025 transactions. The disclosure clarifies the contingent nature of the rights and their alignment with underlying equity awards, satisfying transparency expectations for Section 16 reporting. There are no indications of unusual timing or cash consideration that would raise governance concerns.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Dividend Equivalent Rights (DSUs) | 23 | $0.00 | -- |
| Grant/Award | Dividend Equivalent Rights (2025 RSUs) | 5 | $0.00 | -- |
Footnotes (1)
- The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. The dividend equivalent rights accrued in respect of the 2025 grant of restricted share units (RSU), and become exercisable proportionately with the restricted share units to which they relate.
